STUART, FL – September 12, 2017 – Tony Paquin, Co-Founder and CEO of The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), today reported that the Company’s team has completed a full assessment of iRemedy’s business and technology operations and inspection of its warehousing facilities in the aftermath of Hurricane Irma; and is pleased to confirm that the impact of the storm on iRemedy was minor, limited largely to loss of power. Moreover, iRemedy’s employees and their families are thankfully all safe and accounted for. As of this afternoon, business operations have resumed and iRemedy Supply orders are being processed and fulfilled. It is important to note, however, that there may be some delay in standard delivery times due to national carrier delays caused by or relating to the storm.

Paquin stated, “While we feel very blessed that Hurricane Irma spared our people and our facilities, the same may not be true for some of our medical product suppliers based in Florida. We have been actively reaching out to each of our vendors operating in the State to confirm their respective operational status and, thus far, have identified only one supplier headquartered in Miami which may have been compromised. Consequently, we will look to redirect orders and drop shipments accordingly to ensure that essential medical supplies and healthcare products are readily accessible and deliverable to and where they are needed by physicians, hospitals and other specialty care providers who have come to rely on iRemedy.”

“I would also like to express just how very appreciative we are of all the hard work that our State and local community leaders committed to helping Floridians prepare for this epic storm. Further, our heartfelt thanks go out to all the brave men and women in local law enforcement, fire and safety and emergency healthcare who put their own lives at risk to help others in need during this horrific ordeal,” concluded Paquin.

About The iRemedy Healthcare Companies
iRemedy owns and operates iRemedySupply.com, fast emerging as America’s preferred healthcare ecommerce marketplace where healthcare consumers come to buy medical supplies, drugs, devices and technologies. Since its market launch in December 2015, thousands of consumers, physicians, nurses, dentists and enterprise users of iRemedy’s Software as a Service (“SaaS”) healthcare ecommerce solutions have joined the fast growing iRemedy community. Built from the ground-up by proven healthcare technology experts, the iRemedy platform brings modern ecommerce-driven, cost-reducing solutions to healthcare by delivering the quality, security and end-to-end supply chain management required by the industry, elegantly combining on-line requisitioning, ordering and purchasing with robust back-end inventory management and fulfillment services. iRemedy further enhances its electronic marketplace value proposition with fully integrated, SaaS-enabled patient engagement tools available to iRemedy’s professional users, including turnkey remote patient monitoring, drug sample program and product recommendation capabilities. For more information, please visit www.iremedy.com.

COMPANY CONTACTS:

Keisha Graham
Director of Marketing
407-395-4283 | keisha@iremedy.com
Dodi Handy
VP, Investor Relations
407-960-4636 | dodi@iremedy.com
Comments are closed.